Table 5.
Attribute | Parameter (Level) | Class 1a (Predicted Share, 43%b) |
Class 2 (Predicted Share, 47%) |
Class 3 (Predicted Share, 10%) |
|||
---|---|---|---|---|---|---|---|
Marginal Effect | 95% CI | Marginal Effect | 95% CI | Marginal Effect | 95% CI | ||
Opt-out constant | 0.58 | –0.81 to 1.98 | –0.72 | –1.7 to 0.25 | 4.30c | 2.16 to 6.44 | |
Lung function | Modest deterioration (–5%) | –0.11 | –0.98 to 0.75 | –1.11c | –1.64 to –0.57 | –0.92 | –1.91 to 0.06 |
No change | Referent | ||||||
Modest improvement (+5%) | 0.97d | 0.11 to 1.83 | 0.97c | 0.6 to 1.35 | 0.2 | –0.78 to 1.19 | |
Excellent improvement (+15%) | 1.85e | 0.7 to 3 | 1.73c | 1.16 to 2.31 | 0.83 | –0.35 to 2.01 | |
Need for IV antibiotics | No change | Referent | |||||
One-half the number of IV courses | 0.27 | –0.24 to 0.78 | 0.52c | 0.27 to 0.77 | –0.21 | –0.83 to 0.42 | |
Abdominal symptoms | No change | Referent | |||||
Improvement in symptoms | –0.09 | –0.68 to 0.5 | 0.57e | 0.23 to 0.91 | 0.17 | –0.58 to 0.93 | |
Improvement in symptoms and a reduction in pancreatic enzymes | 0.21 | –0.35 to 0.77 | 0.67c | 0.32 to 1.02 | 0.34 | –0.47 to 1.15 | |
Life expectancy | No change | Referent | |||||
Increases by 5 y | 1.85c | 0.94 to 2.75 | 0.49 | –0.02 to 1.01 | 1.79e | 0.45 to 3.12 | |
Increases by 10 y | 4.79c | 3.57 to 6.02 | 1.49c | 0.96 to 2.01 | 2.45e | 1.04 to 3.86 | |
Increases by 15 y | 6.62c | 5.08 to 8.16 | 1.71c | 1.1 to 2.32 | 3.05c | 1.51 to 4.59 | |
Overall quality of life | No change | Referent | |||||
Good improvement (+10%) | 0.89c | 0.37 to 1.42 | 0.29 | 0 to 0.58 | 0.46 | –0.35 to 1.27 | |
Excellent improvement (20%) | 1.14c | 0.57 to 1.71 | 0.9c | 0.56 to 1.25 | 0.72 | –0.08 to 1.52 | |
Use of inhaled medicines | No change | Referent | |||||
A modest reduction in time spent (25%) | 0.24 | –0.37 to 0.85 | 0.20 | –0.11 to 0.5 | 1.13e | 0.29 to 1.97 | |
A large reduction in time spent (50%) | 0.95e | 0.41 to 1.49 | 0.34e | 0.03 to 0.65 | 0.99e | 0.08 to 1.9 | |
Physiotherapy/ACT | No change | Referent | |||||
Time spent on physiotherapy is halved | 0.53e | 0.02 to 1.04 | 0.17 | –0.1 to 0.45 | 0.45 | –0.32 to 1.22 | |
Able to fully stop physiotherapy | 0.71 | –0.17 to 1.59 | 0.80c | 0.47 to 1.13 | 0.91e | 0.08 to 1.74 | |
Model statistics | No. of observations, 3,708; McFadden R2, N/A; LL, –697; AIC, 1,501; BIC, 1,831 |
ACT = airway clearance therapy; AIC = Akaike information criterion; BIC = Bayesian information criterion; LL = log likelihood; N/A = not applicable.
As marginal effects are calculated relative to the reference level for each class, they are not directly comparable across classes; the ratios between effects, however, may be directly compared.
Probability of class membership equates to percentage class share of the population.
P < .001.
P < .1.
P < .05.